Suspension of trading
Quotes Adaptimmune Therapeutics plc Börse Stuttgart
Stocks
473A
US00653A1079
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0100 EUR | -.--% |
|
-41.18% | -9.09% |
| 05-19 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Performance
| 1 week | -41.18% | ||
| 6 months | -68.75% | ||
| Current year | -9.09% | ||
| 1 year | -96.03% | ||
| 3 years | -99.16% | ||
| 5 years | -99.77% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
8,428,640
Market Cap (USD)
8,428,640
Net sales (USD)
5,924,000
Free-Float
14.03 %
Free-Float capitalization (EUR)
8,159,213
Free-Float capitalization (USD)
7,092,804
Indicators
Moving average 5 days
0.0114
Moving average 20 days
0.0128
Moving average 50 days
0.0098
Moving average 100 days
0.0128
Price spread / (MMA5)
+14.00%
Price spread / (MMA20)
+28.00%
Price spread / (MMA50)
-2.00%
Price spread / (MMA100)
+28.00%
RSI 9 days
46.64
RSI 14 days
48.27
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -41.18% | -96.03% | -99.16% | 8.43M | |
| -0.56% | +16.25% | +36.46% | +4.17% | 76.15B | |
| -0.67% | -8.50% | +21.80% | +183.82% | 48.89B | |
| -2.75% | +48.50% | +48.50% | +48.50% | 47.83B | |
| +1.01% | +6.80% | -53.08% | -53.45% | 41.37B | |
| -0.16% | +0.38% | +53.81% | -25.27% | 29.99B | |
| -0.13% | +1.57% | +58.12% | +81.97% | 24.23B | |
| +4.72% | +1.39% | +98.59% | -50.26% | 21.89B | |
| -0.81% | -3.75% | -7.43% | +162.20% | 19.25B | |
| -7.20% | -3.41% | +66.12% | +119.06% | 17.14B | |
| Average | -1.53% | +1.05% | +22.69% | +37.16% | 32.67B | |
| Weighted average by Cap. | -0.46% | +2.49% | +31.02% | +45.00% |
Historical Quotes: Adaptimmune Therapeutics plc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| 1 week | 0.01 |  | 0.02 |
| 1 month | 0 | | 0.02 |
| 3 years | 0 | | 1.64 |
| 5 years | 0 | | 5.6 |
Monthly variations
Annual variations
| 2026 | -9.09% | ||
| 2025 | -98.00% | ||
| 2024 | -15.38% | ||
| 2023 | -48.00% | ||
| 2022 | -63.24% | ||
| 2021 | -18.27% | ||
| 2020 | +232.80% | ||
| 2019 | -69.95% | ||
| 2018 | -25.06% | ||
| 2017 | +46.93% | ||
| 2016 | -63.06% |
- Stock Market
- Stocks
- ADAPY Stock
- 473A Stock
- Quotes Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
